Skip to content

The efficacy of transdermal nicotine patches for post-operative pain relief in Arthroscopic Shoulder Surgical patients at Phramongkutklao Hospital

The efficacy of transdermal nicotine patches for post-operative pain relief in Arthroscopic Shoulder Surgical patients at Phramongkutklao Hospital

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
TCTR
Registry ID
TCTR20160804001
Enrollment
Unknown
Registered
2016-08-04
Start date
2015-02-06
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients undergoing elective arthroscopic shoulder surgery performed during February to September 2015 at Phramongklao hospital were enrolled in this study. Transdermal nicotine patch&#44

Interventions

Nicotine&#44
the primary psychoactive component of cigarette smoke&#44
was found to have anti&#45
nociceptive effects in animal and volunteer studies via activation of descending central inhibitory pain pathways&#44
and via peripheral action. A systematic review and meta&#45
analysis of nicotine for postoperative analgesia suggests that perioperative nicotine administration was associated with a reduction in cumulative opioid consumption but no reduction in 24&#45
hour postoperative pain scores. All nine studies included in this systematic review were conducted in visceral pain operation&#44
such as pelvic and abdominal surgery&#44
which associated with silent nociceptors and autonomic nervous system. Although nicotine is widely acknowledged to possess visceral analgesic properties&#44
there are surprisingly no clinical studies in the literature evaluating its analgesic effects on somatic pain. ,Placebo
Active Comparator Drug,Placebo Comparator Drug
Transdermal nicotin patches,Placebo patches

Sponsors

Phramongkutklao hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: Patients were eligible for enrollment if they were classified in American Society of Anesthesiologist (ASA) Physical Status (PS) Classification I to II, had no clinically significant cardiovascular or CNS disease, and could operate a patient-controlled analgesia (PCA) device.

Exclusion criteria

Exclusion criteria: Exclusion criteria were known allergy to any of the study medications, contraindications to the use of the PCA morphine or any anesthetic drugs, chronic pain syndromes, a history of uncontrolled hypertension, myocardial disease, stroke, respiratory disease, pregnancy and the use of brachial plexus block during the operation.

Design outcomes

Primary

MeasureTime frame
verbal NRS scores at recovery room arrival, 1st hour and 24th hour postoperatively none The Wilcoxon Signed Ranks Test

Secondary

MeasureTime frame
Intravenous PCA morphine consumption at recovery room arrival, 1st hour and 24th hour postoperativel none Mann-Whitney U test

Countries

Thailand

Contacts

Public ContactSithapan Munjupong

Phramogkutklao Hospital

sithapan@gmail.com0991959255

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026